You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mesothelioma, lung cancer, malignant mesothelioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

Active, not recruiting
  • Cancer
  • +6 more
  • UV1 vaccine + leukine
  • +2 more
  • Perth, Australia
  • +6 more
Jan 23, 2023

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
Has Results
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Lung Cancer, Mesothelioma Trial in Houston (Alisertib)

Completed
Has Results
  • Lung Cancer
  • Mesothelioma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 23, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting
  • Biphasic Mesothelioma
  • +9 more
  • Pembrolizumab
  • +2 more
  • Chicago, Illinois
    University of Chicago
Apr 18, 2022

Non Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Urothelial Carcinoma Trial in Augusta (Cabozantinib,

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Mar 6, 2022

Pleural Malignant Mesothelioma Trial in Houston (other, radiation, biological)

Recruiting
  • Pleural Malignant Mesothelioma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2022

Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Recruiting
  • Lung Cancer Adenocarcinoma
  • +2 more
    • Sohag, Egypt
      Faculty of Medicine, Sohag University
    Jan 27, 2022

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

    Recruiting
    • Non Small Cell Lung Cancer
    • Mesothelioma
    • 's-Hertogenbosch, Netherlands
    • +4 more
    Sep 9, 2022

    Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma Metastatic
    • +4 more
    • (no location specified)
    Jan 13, 2023

    Blood and Tissue in Cancers of Lung, Esophagus and Lung Lining

    Recruiting
    • Malignant Pleural Mesotheliomas NOS
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2023

      Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced Trial in Beijing

      Not yet recruiting
      • Mesothelioma, Malignant
      • +2 more
      • Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences
      Dec 27, 2021

      Lung Adenocarcinoma, Ovarian Cancer, Peritoneal Carcinoma Trial in Philadelphia (huCART-meso cells)

      Recruiting
      • Lung Adenocarcinoma
      • +5 more
      • huCART-meso cells
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 1, 2022

      Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer Trial in Baltimore (AG-01 Compound)

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • AG-01 Compound
      • Baltimore, Maryland
        University of Maryland Greenebaum Comprehensive Cancer Center
      Nov 16, 2022

      Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

      Recruiting
      • Neoplasms
      • +13 more
      • HTL0039732 Capsules
      • HTL0039732 Capsules and atezolizumab infusion
      • Cambridge, United Kingdom
      • +4 more
      Jul 5, 2023

      Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

      Terminated
      • Non Small Cell Lung Cancer
      • Mesothelioma
      • 's-Hertogenbosch, Netherlands
      • +4 more
      May 9, 2022

      Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

      Recruiting
      • Breast Cancer
      • +12 more
      • Checkpoint Blockade, Immune
      • Brussel, Anderlecht, Belgium
        Institut Jules Bordet
      Jul 1, 2022

      Breast Cancer, Glioblastoma, Head and Neck Squamous Cell Carcinoma Trial (PRT3645)

      Not yet recruiting
      • Breast Cancer
      • +5 more
      • (no location specified)
      Sep 9, 2022

      Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

      Completed
      • Non Small Cell Lung Cancer
      • Mesothelioma
      • 's-Hertogenbosch, Netherlands
      • +4 more
      May 9, 2022

      Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

      Recruiting
      • Microsatellite High Cancers
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 8, 2022

      Malignant Mesothelioma (MPM) Trial in United States (Avelumab, Stereotactic Body Radiation Therapy)

      Active, not recruiting
      • Malignant Mesothelioma (MPM)
      • Avelumab
      • Stereotactic Body Radiation Therapy
      • Basking Ridge, New Jersey
      • +6 more
      Mar 7, 2022

      CD30-Positive Neoplastic Cells Present, Malignant Mesothelioma Trial in Houston (Brentuximab Vedotin, Laboratory Biomarker

      Recruiting
      • CD30-Positive Neoplastic Cells Present
      • Malignant Mesothelioma
      • Brentuximab Vedotin
      • Laboratory Biomarker Analysis
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 3, 2022

      Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

      Not yet recruiting
      • Anal Squamous Cell Carcinoma
      • +7 more
      • Regorafenib in combination with Tislelizumab
      • (no location specified)
      Oct 12, 2022

      Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,

      Active, not recruiting
      • Malignant Pleural Disease
      • +4 more
      • iCasp9M28z T cell infusions
      • +2 more
      • Basking Ridge, New Jersey
      • +5 more
      Nov 14, 2022